ANN ARBOR, Mich., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, announces the launch of a key hiring initiative at its production operations in Southeast Asia. This expansion of the Company's production workforce is driven by rapidly increasing throughput, an expanded operational footprint, and preparations for the opening of its newest production center, now in active development. The Company is ramp ...

Core Insights - Kraig Biocraft Laboratories, Inc. is fulfilling an order for spider silk from a globally recognized performance sports apparel brand as part of a confidential pilot development program [1][2] - The project aims to incorporate next-generation recombinant spider silk into high-performance apparel, targeting a demanding segment of the athletic market [2][5] - The collaboration highlights the growing recognition of spider silk's potential in high-value applications, aligning with the customer's commitment to innovation [6] Company Developments - The company is processing its recombinant spider silk inventory into yarns tailored to the specifications provided by the customer's development team, with delivery expected before the end of the first quarter [4] - This pilot program involves a small, purpose-built quantity of spider silk, serving as a platform to demonstrate the technology's performance capabilities [5] - Kraig Labs' CEO expressed excitement about the collaboration, emphasizing the alignment of innovation between the company and the customer [6] Industry Context - Kraig Biocraft Laboratories is recognized as a leader in genetically engineered spider silk-based fiber technologies, with significant breakthroughs impacting the global textile industry [8]

Core Insights - Kraig Biocraft Laboratories, Inc. has launched its sixth spider silk production cycle for 2025, featuring the BAM-1 Alpha, the latest advancement in its recombinant spider silk technology [1][2] - The company is experiencing renewed momentum and enhanced output capability following a year of record technical progress and expanded production [2][3] Production and Technology - The BAM-1 Alpha hybrid builds on the company's 2024 breakthroughs, offering stronger performance and higher silk yields while adhering to an aggressive production schedule [2][4] - The integration of diapause egg management into rearing operations has improved production efficiency and logistics, allowing for sustained throughput across multiple cycles [3][4] Strategic Positioning - The transition to BAM-1 Alpha does not require changes to the existing production schedule or rearing infrastructure, resulting in increased silk output per cycle [4] - The company emphasizes its leadership in sustainable, high-performance bioengineered super fibers, positioning itself for commercial expansion to meet growing demand [4][5]

Core Insights - Kraig Biocraft Laboratories, Inc. is advancing its spider silk production capabilities by adding a second parallel production facility, developing three new spider silk strains, and implementing a new diapausing system for production, aimed at significantly increasing production yields and quality [1][2][10] Production Enhancements - The company is finalizing a lease for a second rearing center, with parental strain rearing expected to commence within 30 days [3] - Three new spider silk strains have been developed to enhance hybrid vigor and silk yield, with one strain intended to replace an existing BAM-1 parent line [4] - The introduction of diapausing silkworm strains, which undergo a 90-day cold treatment, is expected to yield stronger silk and larger cocoons, aligning with the company's commitment to high-quality production [5][7] Production Model Transition - The current batch production model limits output to 8 or 9 batches per year; the new parallel facilities and diapausing egg production will enable nearly continuous production [6] - The two facilities will operate in tandem, ensuring a continuous flow of eggs for production, thereby dramatically expanding overall production capacity [6] Strategic Goals - The transition to a diapausing hybrid system is part of the company's long-term vision to deliver high-quality spider silk at a commercial scale, addressing growing industry demand [9][10] - The latest batch of BAM-1 finished spider silk has brought the company closer to fulfilling a significant request from a renowned European fashion house, indicating strong market interest [8][10]